Sessionsort descending Date
“Missed Germline Pathogenic Mutations: Causes, Consequences & Corrective Actions" 04/23/2018 - 12:00pm to 1:00pm
“Neoadjuvant Pembrolizumab in Resectable Early Stage Gastroesophageal Adenocarcinoma” and “Overcoming Oncogene-Mediated Immune Exclusion to Improve Immunotherapy Responsiveness” 12/18/2017 - 12:00pm to 1:00pm
“Phase II Trial of Pembrolizumab (Pembro) Plus 1 mg/kg Ipilimumab (ipi) Immediately Following Progression on Anti-PD-1-Ab in Melanoma (mel)” 05/21/2018 - 12:00pm to 1:00pm
“Playing Mind Games: Therapeutic Approaches to Primary CNS Lymphoma” and “Beyond Transfusions – Novel Strategies for Treatment of Beta-Thalassemia” 06/18/2018 - 12:00pm to 1:00pm
“Sickle Cell Disease Management in Adults – New Advances and Future Challenges” 04/16/2018 - 12:00pm to 1:00pm
“The Expanding Role of Germline Genetics in Cancer” 11/20/2017 - 12:00pm to 1:00pm
“The Genetics of GIST: Clinical Relevance of Mutations to Prognosis and Management” and “Smoldering Myeloma: Treat Now or Forever Hold Your Peace?" 01/29/2018 - 12:00pm to 1:00pm
“The Role of Innate Immunity in MDS Pathogenesis” 04/09/2018 - 12:00pm to 1:00pm
“Understanding Normal and Malignant Hematopoiesis One Cell At a Time” 11/06/2017 - 12:00pm to 1:00pm
“Updates in Treating Cancer Pain: Medications, Interventions, Functional Status and Beyond” 04/02/2018 - 12:00pm to 1:00pm

Pages